Moalem Weitemeyer assisted Eir Ventures in the transaction.SD Immunotech ApS (“ISD”), a biotech company developing new anti-inflammatory treatments, announced that Eir Ventures have completed an investment…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
